ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 16

$587K Total Retail Price of All Prescriptions

Rank: 9 out of 16

437 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

20% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

1% of this provider’s 9,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 37.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 485 460 1 5
HYDROCODONE-ACETAMINOPHEN 388 333 S3 2 3
AMLODIPINE BESYLATE 366 355 3 7
LEVOTHYROXINE SODIUM 331 327 4 1
FUROSEMIDE 280 255 5 2
LISINOPRIL 263 222 6 4
DONEPEZIL HCL 250 250 7 11
LOSARTAN POTASSIUM 220 216 8 34
METFORMIN HCL 213 197 9 15
ALENDRONATE SODIUM 201 187 10 38
OMEPRAZOLE 192 177 11 8
POTASSIUM CHLORIDE 191 186 12 6
METOPROLOL TARTRATE 186 178 13 10
NAMENDA 142 142 14 14
SERTRALINE HCL 138 137 15 21
CLOPIDOGREL 136 127 16 28
GABAPENTIN 132 112 17 12
LOSARTAN-HYDROCHLOROTHIAZIDE 130 125 18 89
ATORVASTATIN CALCIUM 124 122 19 27
GLIMEPIRIDE 120 120 20 51
HYDROCHLOROTHIAZIDE 120 104 20 25
CARVEDILOL 114 108 22 18
TRIAMTERENE-HCTZ 100 100 23 92
RANITIDINE HCL 100 70 23 17
CLONIDINE HCL 98 98 25 41
ESCITALOPRAM OXALATE 97 94 26 22
METOPROLOL SUCCINATE 90 88 27 24
PLAVIX 87 87 28 46
QUETIAPINE FUMARATE 84 75 29 36
OXYBUTYNIN CHLORIDE 83 71 30 103
CRESTOR 83 71 30 89
ZOLPIDEM TARTRATE 80 76 32 32
TRAMADOL HCL 79 71 33 19
LOVASTATIN 79 79 33 40
MIRTAZAPINE 77 76 35 13
MELOXICAM 77 77 35 52
MICARDIS 72 72 37 187
ONGLYZA 66 55 38 193
KLOR-CON 10 65 60 39 93
DOXAZOSIN MESYLATE 63 57 40 196
PAROXETINE HCL 62 57 41 75
ZETIA 60 60 42 202
ATENOLOL 59 57 43 26
LANTUS 59 58 43 23
PROAIR HFA 59 56 43 86
EXELON 58 58 46 76
CYMBALTA 58 58 46 37
BENAZEPRIL HCL 57 57 48 113
AZITHROMYCIN 55 48 49 83
ENABLEX 53 53 50 138
VYTORIN 53 53 50 213
CITALOPRAM HBR 53 41 50 16
DILTIAZEM 24HR CD 51 39 53 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 49 53 84
KLOR-CON M10 50 49 55 155
ISOSORBIDE MONONITRATE ER 50 27 55 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.